Showing 1 - 10 of 11
Persistent link: https://www.econbiz.de/10003483880
Persistent link: https://www.econbiz.de/10001721630
We study size and growth distributions of products and business firms in the context of a given industry. Firm size growth is analyzed in terms of two basic mechanisms, i.e., the increase of the number of new elementary business units and their size growth. We find a power-law relationship...
Persistent link: https://www.econbiz.de/10012775589
At the intersection between statistical physics and rigorous econometric analysis, this powerful new framework sheds light on how innovation and competition shape the growth and decline of companies and industries. Analyzing various sources of data including a unique micro level database which...
Persistent link: https://www.econbiz.de/10013272381
This paper is explorative in nature. Based on an empirical analysis of two different industrial settings (life sciences, LS; information and communication technologies, ICT), it investigates network growth and firm growth in networks. We find a remarkable correspondence between a few fundamental...
Persistent link: https://www.econbiz.de/10012753755
Persistent link: https://www.econbiz.de/10012294677
Persistent link: https://www.econbiz.de/10012169226
The size distribution of business firms is explained using number and size of firms' constituent components. It is a lognormal distribution multiplied by a stretching factor which can lead to a Pareto upper tail. This result is confirmed empirically
Persistent link: https://www.econbiz.de/10014224793
We introduce a model of proportional growth to explain the distribution Pg(g) of business-firm growth rates. The model predicts that Pg(g) is exponential in the central part and depicts an asymptotic power-law behavior in the tails with an exponent z=3. Because of data limitations, previous...
Persistent link: https://www.econbiz.de/10014048094
This work studies the processes of growth of the worlds top 150 pharmaceutical firms, on the grounds of an original database which also allows disaggregate analysis at the level of single therapeutic classes and chemical entities. Our findings show that the industry - whose long - term evolution...
Persistent link: https://www.econbiz.de/10014048107